Apr 01, 2022 13:13 JST
Source: Denso
|
|
Marubeni, OPExPARK, Beyond Next Ventures and DENSO Collaborate to Promote DX in the Healthcare Industry
TOKYO, Apr 01, 2022 - (JCN Newswire) - Marubeni Corporation ("Marubeni"), OPExPARK Inc. ("OPExPARK"), Beyond Next Ventures Inc. ("BNV") and DENSO CORPORATION ("DENSO") have agreed for Marubeni to invest with BNV andin OPExPARK to support the digital transformation ("DX") of operating rooms and a surgical education platform business for doctors ("this project"). OPExPARK was jointly established by DENSO and BNV.
| From left, BNV Executive Officer Katsuya Hashizume, OPExPARK President and CEO Yasunori Honda, Marubeni Executive Officer Chief Operating Officer of the ICT & Real Estate Business Div. Tatsuya Abe, and DENSO Manager Hideki Okuda |
In recent years, the need for DX has been rapidly increasing in the healthcare industry, as represented by the development of new medical services such as telemedicine and online medication guidance, and the utilization of medical data. In addition, with the decrease in the number of surgeries and restrictions on movement, delivering surgical education has been challenging, with young doctors having fewer opportunities to learn techniques from operations that senior doctors perform. Therefore, there is a growing expectation for an educational platform that allows doctors to learn surgical techniques online.
OPExPARK was established in 2019 with the support of BNV, utilizing the information integration platform "OPeLiNK" developed by DENSO with the support of the Japan Agency for Medical Research and Development. OPeLiNK is an information integration platform that constantly provides data gathered from each piece of equipment in the operating room, which is conventionally handled individually, with data in a consistent format so that it can be used by any device. By extracting and delivering accumulated equipment and biological data, information important to the decision-making of the surgeon can be visualized, and advanced tacit knowledge that was difficult to learn outside the operating room can be shared. OPExPARK promotes DX of surgical education through the delivery of educational contents that enables anyone to learn cutting-edge surgery anytime, anywhere. In addition, OPExPARK contributes to the improvement of the quality of medical care in Japan and overseas by transmitting surgical videos and data acquired by OPELiNK in real time and by providing advice on diagnosis and surgery from remote locations.
Marubeni has strengthened and expanded its IT consulting services business and cloud integration business to support and promote DX for customers and partners. By investing in this project and utilizing its cultivated know-how of DX support and promotion, support for IT fields (including the cloud), and cooperation with other businesses, Marubeni will contribute to the expansion of OPExPARK's services from DX in operating rooms and surgical education to DX in hospitals. By acquiring knowledge, networks, and business know-how in the healthcare industry through participation in this project, Marubeni aims to expand business in the digital health industry by promoting DX and developing new services in the field of drug discovery and clinical trial support in the future.
Since 2018, BNV has been involved in the establishment of OPExPARK (with carve-out support from DENSO) and support for its business growth. In establishing the company, BNV developed initial business strategies, business plans, and support for management team organization through "BRAVE", an acceleration program provided by BNV. After the company's establishment, BNV has been involved in continuous investment, recruitment, business development, and business growth support.
From 2014 to 2019, DENSO developed OPeLiNK and has been developing businesses that raise the medical level in emerging countries by utilizing the surgical information acquired through OPeLiNK. Even after OPExPARK's founding, DENSO has continued to acquire know-how in the digital twin business, support OPExPARK through joint research, and dispatch both technical and sales employees to the company.
Through this agreement and this project, Marubeni, OPExPARK, BNV, and DENSO will promote DX in the healthcare industry and contribute to the improvement of medical quality.
For more information, visit https://www.denso.com/global/en/.
Source: Denso Sectors: MedTech
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
|
Latest Release
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date Apr 24, 2024 17:19 JST
| MC and Denka Sign J/V Agreement in Fullerene Business Apr 24, 2024 17:02 JST
| Mitsubishi Motors Posts Record Sales in the Philippines in FY2023 Apr 24, 2024 13:56 JST
| NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance Apr 24, 2024 13:25 JST
| Fujitsu SX Survey reveals key success factors for sustainability Apr 23, 2024 10:25 JST
| Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions Apr 22, 2024 16:09 JST
| NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II Apr 22, 2024 15:09 JST
| Soft Space Launches the First and Only JCB Payment Gateway in Malaysia Apr 22, 2024 15:00 JST
| TOYOTA GAZOO Racing takes a one-two in Croatian thriller Apr 22, 2024 10:47 JST
| First-ever Mazda CX-80 Crossover SUV Unveiled in Europe Apr 19, 2024 13:50 JST
| Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces Apr 19, 2024 10:17 JST
| Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas Apr 18, 2024 17:01 JST
| Toyota Launches All-New Land Cruiser "250" Series in Japan Apr 18, 2024 13:39 JST
| Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan Apr 18, 2024 11:14 JST
| Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category) Apr 18, 2024 10:53 JST
| All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating Apr 18, 2024 09:22 JST
| Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan Apr 17, 2024 16:17 JST
| Honda Unveils Next-generation EV Series for China Apr 17, 2024 12:15 JST
| Lexus presents Time at the 2024 Milan Design Week Apr 16, 2024 18:49 JST
| Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA Apr 16, 2024 14:36 JST
|
More Latest Release >>
|